AR014922A1 - Compuesto derivado de indol util en terapia, proceso para su preparacion, formulaciones farmaceuticas y procedimiento de tratamiento. - Google Patents
Compuesto derivado de indol util en terapia, proceso para su preparacion, formulaciones farmaceuticas y procedimiento de tratamiento.Info
- Publication number
- AR014922A1 AR014922A1 ARP980105232A ARP980105232A AR014922A1 AR 014922 A1 AR014922 A1 AR 014922A1 AR P980105232 A ARP980105232 A AR P980105232A AR P980105232 A ARP980105232 A AR P980105232A AR 014922 A1 AR014922 A1 AR 014922A1
- Authority
- AR
- Argentina
- Prior art keywords
- useful
- indol
- therapy
- preparation
- processing procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe el ácido (S)-(+)-3-{1-(1,3-benzodioxol-5-il)-2-[(2-metoxi-4- metilfenil)sulfonilamino]-2-oxoetil}-1-metil-1h-indol-6-carboxílico, que estáen gran parte libre de su enantiomero (R)- (-), y derivados farmacéuticamente aceptables del mismo.Los compuestos son utiles en el tratamiento de la insuficiencia renal aguda inter alia, reestenosis e hipertension pulmonar. Se describen también procesosde preparacion y formulaciones farmacéuticas y procedimiento de tratamiento que utilizadicho compuesto (I).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9722287.1A GB9722287D0 (en) | 1997-10-22 | 1997-10-22 | Compounds useful in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014922A1 true AR014922A1 (es) | 2001-04-11 |
Family
ID=10820904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105232A AR014922A1 (es) | 1997-10-22 | 1998-10-20 | Compuesto derivado de indol util en terapia, proceso para su preparacion, formulaciones farmaceuticas y procedimiento de tratamiento. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6211223B1 (es) |
| AP (1) | AP899A (es) |
| AR (1) | AR014922A1 (es) |
| AU (1) | AU1150999A (es) |
| BG (1) | BG104394A (es) |
| CA (1) | CA2308478C (es) |
| CZ (1) | CZ20001514A3 (es) |
| DZ (1) | DZ2628A1 (es) |
| GB (1) | GB9722287D0 (es) |
| GT (1) | GT199800161A (es) |
| MA (1) | MA26556A1 (es) |
| MY (1) | MY117148A (es) |
| PA (1) | PA8461001A1 (es) |
| TN (1) | TNSN98190A1 (es) |
| TW (1) | TW483893B (es) |
| WO (1) | WO1999020623A1 (es) |
| ZA (1) | ZA989574B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9722287D0 (en) | 1997-10-22 | 1997-12-17 | Pfizer Ltd | Compounds useful in therapy |
| AR037097A1 (es) | 2001-10-05 | 2004-10-20 | Novartis Ag | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento |
| CN106631920B (zh) * | 2016-11-17 | 2018-11-13 | 贵州大学 | 一种2-羟基-4-甲基苯磺酸的制备方法 |
| CN114507162A (zh) * | 2020-11-16 | 2022-05-17 | 尚科生物医药（上海）有限公司 | 一种制备2-氟-5-甲氧基苯磺酰氯的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE189217T1 (de) * | 1993-03-19 | 2000-02-15 | Merck & Co Inc | Phenoxyphenylessigsäurederivate |
| GB9609641D0 (en) * | 1996-05-09 | 1996-07-10 | Pfizer Ltd | Compounds useful in therapy |
| GB9722287D0 (en) | 1997-10-22 | 1997-12-17 | Pfizer Ltd | Compounds useful in therapy |
-
1997
- 1997-10-22 GB GBGB9722287.1A patent/GB9722287D0/en not_active Ceased
-
1998
- 1998-09-30 PA PA19988461001A patent/PA8461001A1/es unknown
- 1998-10-03 TW TW087116502A patent/TW483893B/zh not_active IP Right Cessation
- 1998-10-06 AU AU11509/99A patent/AU1150999A/en not_active Abandoned
- 1998-10-06 CA CA002308478A patent/CA2308478C/en not_active Expired - Fee Related
- 1998-10-06 CZ CZ20001514A patent/CZ20001514A3/cs unknown
- 1998-10-06 WO PCT/EP1998/006354 patent/WO1999020623A1/en not_active Application Discontinuation
- 1998-10-19 GT GT199800161A patent/GT199800161A/es unknown
- 1998-10-20 AR ARP980105232A patent/AR014922A1/es not_active Application Discontinuation
- 1998-10-20 MY MYPI98004785A patent/MY117148A/en unknown
- 1998-10-21 DZ DZ980238A patent/DZ2628A1/xx active
- 1998-10-21 TN TNTNSN98190A patent/TNSN98190A1/fr unknown
- 1998-10-21 MA MA25307A patent/MA26556A1/fr unknown
- 1998-10-21 ZA ZA9809574A patent/ZA989574B/xx unknown
- 1998-10-22 AP APAP/P/1998/001370A patent/AP899A/en active
-
2000
- 2000-04-18 US US09/551,779 patent/US6211223B1/en not_active Expired - Fee Related
- 2000-04-28 BG BG104394A patent/BG104394A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW483893B (en) | 2002-04-21 |
| CA2308478A1 (en) | 1999-04-29 |
| AU1150999A (en) | 1999-05-10 |
| GB9722287D0 (en) | 1997-12-17 |
| TNSN98190A1 (fr) | 2005-03-15 |
| CZ20001514A3 (cs) | 2001-09-12 |
| PA8461001A1 (es) | 2000-05-24 |
| DZ2628A1 (fr) | 2003-03-08 |
| AP899A (en) | 2000-11-17 |
| GT199800161A (es) | 2000-04-11 |
| ZA989574B (en) | 2000-04-25 |
| MY117148A (en) | 2004-05-31 |
| AP9801370A0 (en) | 1998-12-31 |
| BG104394A (en) | 2001-09-28 |
| US6211223B1 (en) | 2001-04-03 |
| MA26556A1 (fr) | 2004-12-20 |
| WO1999020623A1 (en) | 1999-04-29 |
| CA2308478C (en) | 2004-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR007030A1 (es) | Un compuesto derivado de indol, su uso, un procedimiento para producirlo, y una composicion farmaceutica que lo contiene | |
| BR9712085A (pt) | Inibidores de metaloprotease heterocìclicos | |
| FR2430412B1 (fr) | Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation | |
| EA200000488A1 (ru) | Замена катехина на биоизостеру индазола в терапевтически активных соединениях | |
| AR008853A1 (es) | Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos | |
| RU95116357A (ru) | Производные пирролидина и тиазолидина, способы их получения, способ разделения энантиомеров и фармацевтическая композиция на основе производных пирролидина и тиазолидина | |
| EA200100203A1 (ru) | Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов | |
| MX9404885A (es) | Derivados de ariliden y heteroariliden oxindoles, proceso para supreparacion y composiciones farmaceuticas que los contienen. | |
| NO982222D0 (no) | 3-(4-Subst.-piperidinyl-1)-1-(3,4-diklorfenyl)propylkarbamater og -ureaer og derivater som neurokinin-antagonister | |
| ES2166470T3 (es) | Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a. | |
| FI840463A0 (fi) | Vissa bensazokinon- och bensazoninonderivat | |
| TR200001906T2 (tr) | Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri. | |
| EA200000023A1 (ru) | Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола | |
| NO930035L (no) | Eksitatoriske aminosyreantagonister | |
| PT83535B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos | |
| ATE19397T1 (de) | (+)-2-(1-(2,6-dichlorphenoxy)-ethy1)-1,3diazacyclopent-2-en,dessen herstellung und seine verwendung in pharmazeutischen praeparaten. | |
| MX9604687A (es) | Procedimiento para la preparacion de derivados de imidazo-benzodiacepina. | |
| TR199700206A2 (xx) | Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�. | |
| AR014922A1 (es) | Compuesto derivado de indol util en terapia, proceso para su preparacion, formulaciones farmaceuticas y procedimiento de tratamiento. | |
| ATE254122T1 (de) | Indolderivate als 5-ht1b und 5-ht1d agonisten | |
| NO20014855D0 (no) | N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister | |
| ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
| FI853763A0 (fi) | 1,3-dimetyl-1h-purin-2,6-dioner, som innehaoller 1h-indol-3-yl. | |
| EA200000322A1 (ru) | Способ синтеза производных хинолина | |
| EA200000561A1 (ru) | Триазиновые соединения для лечения расстройств цнс |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |